Tag: South Korea

SK Biopharmaceuticals created novel drug development platform

drug discovery
SK Biopharmaceuticals, the new drug development unit of South Korea’s conglomerate SK Group, had finished developing an artificially intelligent drug development and design platform.

Korean scientists unveiled biosensor for optimizing microbial cell factories

stem-cell
A research group at Korea Advanced Institute of Science and Technology (KAIST) presented a novel biosensor which can produce diverse, high-level microbial cell factories.

Merck KGaA gets hold on $117 million contract for Samsung biosimilar

biosimilars
Merck KGaA, a global health care company, has won a $117 million contract to supply the biosimilar Renflexis, developed by Samsung Bioepis Co., to the U.S. Department of Veterans Affairs.

Russia and South Korea will jointly develop biotechnology R&D

biotechnology
The Russian Direct Investment Fund (RDIF), JSFC Sistema, the Medsi Group of Companies, have agreed with the South Korean company Green Cross Cell to develop jointly biotechnology in Russia.

South Korea recalls 59 valsartan-containing drugs

counterfeit drug
South Korea’s Ministry of Food and Drug Safety ordered a recall of 59 drugs containing valsartan due to its inclusion of above-permitted levels of a chemical that could cause cancer.

The finished medicinal product market of South Korea shows significant growth

pills
South Korea's pharmaceutical market is experiencing significant growth in finished drug products, according to CPhI Korea.

Global biotech conference started in South Korea

korea
The 2018 Global Bio Conference kicked off in Seoul, bringing together biotech regulators and industry experts from around the world to support the growth and overseas expansion of South Korea’s biopharmaceutical businesses.

Pharma Research Products gains a generic botulinum toxin production company

injection
Pharma Research Products Company Ltd. (PRP) a Korean company engaged in the development of medical esthetic products, secured majority ownership of botulinum toxin type A injection production facility of BioCND.

Samsung BioLogics is concerned about the accusation of accounting fraud

samsung biologics
South Korea’s major biopharmaceutical firm Samsung BioLogics Co., which has been embroiled in an alleged violation of accounting rules, expressed concern over the local financial regulator’s disclosure of sensitive information.

South Korea will support AI drug development

drug discovery
South Korea’s largest biopharmaceutical business association has kickstarted preparations for a support center that will leverage artificial intelligence to help pharmaceutical companies accelerate new drug development processes

South Korea doubles its investments in the pharmaceutical sector

korea
South Korea pledged to double its investments in the pharmaceutical sector to help develop 15 new drugs in the next five years